Annual Net Income
-$327.26 M
+$13.15 M+3.86%
31 December 2023
Summary:
Allogene Therapeutics annual net profit is currently -$327.26 million, with the most recent change of +$13.15 million (+3.86%) on 31 December 2023. During the last 3 years, it has fallen by -$10.88 million (-3.44%). ALLO annual net income is now -79.77% below its all-time high of -$182.05 million, reached on 31 December 2021.ALLO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$66.29 M
+$65.00 K+0.10%
30 September 2024
Summary:
Allogene Therapeutics quarterly net profit is currently -$66.29 million, with the most recent change of +$65.00 thousand (+0.10%) on 30 September 2024. Over the past year, it has dropped by -$4.01 million (-6.43%). ALLO quarterly net income is now -77184.88% below its all-time high of $86.00 thousand, reached on 31 December 2021.ALLO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$283.43 M
-$4.01 M-1.43%
30 September 2024
Summary:
Allogene Therapeutics TTM net profit is currently -$283.43 million, with the most recent change of -$4.01 million (-1.43%) on 30 September 2024. Over the past year, it has increased by +$60.69 million (+17.64%). ALLO TTM net income is now -10813.71% below its all-time high of -$2.60 million, reached on 31 March 2018.ALLO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | -6.4% | +17.6% |
| 3 y3 years | -3.4% | +15.2% | +10.6% |
| 5 y5 years | -54.7% | -30.7% | -84.0% |
ALLO Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -79.8% | +3.9% | <-9999.0% | +35.4% | -55.7% | +22.3% |
| 5 y | 5 years | -79.8% | +3.9% | <-9999.0% | +50.8% | -84.0% | +22.3% |
| alltime | all time | -79.8% | +3.9% | <-9999.0% | +50.9% | <-9999.0% | +22.3% |
Allogene Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$66.29 M(-0.1%) | -$283.43 M(+1.4%) |
| June 2024 | - | -$66.36 M(+2.1%) | -$279.42 M(-4.4%) |
| Mar 2024 | - | -$65.00 M(-24.2%) | -$292.30 M(-10.7%) |
| Dec 2023 | -$327.26 M(-3.9%) | -$85.78 M(+37.7%) | -$327.26 M(-4.9%) |
| Sept 2023 | - | -$62.29 M(-21.4%) | -$344.12 M(-5.7%) |
| June 2023 | - | -$79.23 M(-20.7%) | -$364.98 M(+1.2%) |
| Mar 2023 | - | -$99.97 M(-2.6%) | -$360.53 M(+5.9%) |
| Dec 2022 | -$340.41 M(+87.0%) | -$102.63 M(+23.4%) | -$340.41 M(+43.2%) |
| Sept 2022 | - | -$83.15 M(+11.2%) | -$237.70 M(+2.1%) |
| June 2022 | - | -$74.79 M(-6.3%) | -$232.74 M(+1.7%) |
| Mar 2022 | - | -$79.85 M(<-9900.0%) | -$228.89 M(+25.7%) |
| Dec 2021 | -$182.05 M | $86.00 K(-100.1%) | -$182.05 M(-42.5%) |
| Sept 2021 | - | -$78.19 M(+10.2%) | -$316.87 M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$70.94 M(+114.9%) | -$304.88 M(+3.4%) |
| Mar 2021 | - | -$33.02 M(-75.5%) | -$294.92 M(-6.8%) |
| Dec 2020 | -$316.38 M(+71.4%) | -$134.73 M(+103.5%) | -$316.38 M(+30.4%) |
| Sept 2020 | - | -$66.20 M(+8.6%) | -$242.68 M(+6.8%) |
| June 2020 | - | -$60.97 M(+11.9%) | -$227.22 M(+9.5%) |
| Mar 2020 | - | -$54.48 M(-10.7%) | -$207.49 M(+12.4%) |
| Dec 2019 | -$184.59 M(-12.7%) | -$61.03 M(+20.3%) | -$184.59 M(+19.8%) |
| Sept 2019 | - | -$50.73 M(+23.0%) | -$154.07 M(+4.9%) |
| June 2019 | - | -$41.24 M(+30.6%) | -$146.84 M(-38.9%) |
| Mar 2019 | - | -$31.59 M(+3.5%) | -$240.49 M(+13.7%) |
| Dec 2018 | -$211.50 M | -$30.51 M(-29.9%) | -$211.50 M(+16.9%) |
| Sept 2018 | - | -$43.50 M(-67.8%) | -$181.00 M(+31.6%) |
| June 2018 | - | -$134.90 M(+5094.5%) | -$137.50 M(+5194.5%) |
| Mar 2018 | - | -$2.60 M | -$2.60 M |
FAQ
- What is Allogene Therapeutics annual net profit?
- What is the all time high annual net income for Allogene Therapeutics?
- What is Allogene Therapeutics annual net income year-on-year change?
- What is Allogene Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly net income year-on-year change?
- What is Allogene Therapeutics TTM net profit?
- What is the all time high TTM net income for Allogene Therapeutics?
- What is Allogene Therapeutics TTM net income year-on-year change?
What is Allogene Therapeutics annual net profit?
The current annual net income of ALLO is -$327.26 M
What is the all time high annual net income for Allogene Therapeutics?
Allogene Therapeutics all-time high annual net profit is -$182.05 M
What is Allogene Therapeutics annual net income year-on-year change?
Over the past year, ALLO annual net profit has changed by +$13.15 M (+3.86%)
What is Allogene Therapeutics quarterly net profit?
The current quarterly net income of ALLO is -$66.29 M
What is the all time high quarterly net income for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly net profit is $86.00 K
What is Allogene Therapeutics quarterly net income year-on-year change?
Over the past year, ALLO quarterly net profit has changed by -$4.01 M (-6.43%)
What is Allogene Therapeutics TTM net profit?
The current TTM net income of ALLO is -$283.43 M
What is the all time high TTM net income for Allogene Therapeutics?
Allogene Therapeutics all-time high TTM net profit is -$2.60 M
What is Allogene Therapeutics TTM net income year-on-year change?
Over the past year, ALLO TTM net profit has changed by +$60.69 M (+17.64%)